Annals of Indian Academy of Neurology
  Users Online: 512 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size

Table of Contents
EDITORIAL COMMENTARY
Year : 2019  |  Volume : 22  |  Issue : 4  |  Page : 462-463
 

Familial CJD- A brief commentary


1 Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India
2 Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India

Date of Submission09-Oct-2019
Date of Acceptance09-Oct-2019
Date of Web Publication25-Oct-2019

Correspondence Address:
Prof. Satish Chandra
Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/aian.AIAN_508_19

Rights and Permissions

 



How to cite this article:
Chandra S, Mahadevan A, Shankar S K. Familial CJD- A brief commentary. Ann Indian Acad Neurol 2019;22:462-3

How to cite this URL:
Chandra S, Mahadevan A, Shankar S K. Familial CJD- A brief commentary. Ann Indian Acad Neurol [serial online] 2019 [cited 2019 Nov 17];22:462-3. Available from: http://www.annalsofian.org/text.asp?2019/22/4/462/269919




Prion disease, a transmissible spongiform encephalopathy, is characterized by prominent heterogeneity in pathology unlike relative homogeneity of Alzheimer's disease, Huntington disease, Parkinson's disease and other so called neurodegenerative diseases. Based on mode of acquisition, prion disease could be sporadic, familial or acquired (infectious). The heterogeneity of the prion disease is modulated by PRNP polymorphism at Codon 129 involving methionine (Met) or valine (Val) (Met/Met, Met/Val, or Val/Val) and physicochemical properties of prion protein strain (type 1 PrP Sc or type 2).[1],[2]

Among the Caucasians, 32% of subjects are methionine homozygous (MM), 36% heterozygous (MV), and only 12% are VV homozygous. In Japan, 91.6% of normal population are MM, 8.4% MV and 0% VV.[1] Among sporadic CJD patients, 95% of the MM homozygous belong to PrP sc type I and 86% with VV or MV have PrP sc Type 2 proteins.[3] Similar data is not available among Indian population due to limited availability of genetic testing.

The inherited forms are autosomal dominant with high penetrance and include genetic CJD, FFI, GSS and newly described prion protein cerebral amyloid angiopathy. Not all have a family history, and in its absence, only PRNP mutation provides diagnosis. Over 40 mutations in PRNP gene are identified and polymorphism at Codon 129 and 219 influence the wide range of clinicopathologic phenotypes.[2] E200K-129M is the most common form of familial CJD with clinical phenotype of sporadic CJD.

The D178N-129M haplotype is associated with FFI and the most prevalent form of familial CJD. The duration of illness is variable. The insomnia, myoclonus and autonomic malfunctions are often more severe in 129 MM subjects and ataxia in 129 MV subtypes.[3] The EEG may not show classic PSW. In CSF, 14-3-3 maybe absent. Spongiform change and astrogliosis resent invariably present in cerebral cortex, milder in striatum, diencephalon and cerebellum.[2]

From India, reports of CJD are scarce, with few suspected familial CJD cases from Mumbai and Hyderabad reported to the CJD Registry (personal communication), but no genetic studies could be carried out. Because of infectious nature of CJD the clinicians and pathologists shun autopsy studies and hence cases remain uncharacterized as sporadic or familial; though consanguinity is common in India.[4],[5]

In a previous report, Sehwal et al., 2019 reported an Indian kindred with haplo type of the index case being D178N-129VV.[5] The clinical phenotype was sCJD with insomnia in one member. PRNPD178N is usually associated with FFI phenotype but MM at codon 129, reinforcing disease modulating effect of Codon 129 polymorphism. The unaffected family members revealed a MV polymorphism at codon 129 despite harboring the D128N mutation. Lack of classic triphasic waves on EEG and absence of 14-3-3 in CSF add to the diagnostic dilemma. In the current report, PRNP gene mutation was similar.[6]

Histopathological features are also influenced by the PRNP gene and show florid spongiform change with scant prion plaques in cases with D128N mutation. In the report by Sawal from Delhi, the pathological features are not described as biopsy/autopsy was not conducted.[6] In the current case report, the pathological features described was typical of D128N mutation.[7]

With increasing awareness, CJD is being increasingly suspected by neurologists and need for availability of genetic testing for confirmation is increasing.

To conclude, it is essential to develop scientific collaboration and establish genetic testing facility in India. It is time to establish a referral laboratory for the country to augment the CJD registry to gain realistic epidemiological data for the country.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
   References Top

1.
Iwasaki Y. Creutzfeldt-Jakob disease. Neuropathology 2017;37:174-88.  Back to cited text no. 1
    
2.
Ritchie DL, Ironside JW. Neuropathology of human prion diseases. Prog Mol Biol Transl Sci 2017;150:319-39.  Back to cited text no. 2
    
3.
Gambetti P, Kong Q, Zou W, Parchi P, Chen SG. Sporadic familial CJD Classification and characterization. Br Bull 2003;86:213-39.  Back to cited text no. 3
    
4.
Kher M, Rao MY, Acharya PT, Mahadevan A, Shankar SK. Heidenhain variant of Creutzfeldt-Jakob disease: An autopsy study from India. Ann Indian Acad Neurol 2009;12:48-51.  Back to cited text no. 4
[PUBMED]  [Full text]  
5.
Mahadevan A, Shankar SK, Yasha TC, Santosh V, Sarkar C, Desai AP, et al. Brain biopsy in Creutzfeldt-Jakob disease: evolution of pathological changes by prion protein immune histochemistry. Neuropathol Appl Neurobiol 200228:314-24.  Back to cited text no. 5
    
6.
Sawal N, Chakravarty K, Puri I, Goyal V, Garga A, Shi Qi, et al. Familial CreutzfeldtJakob disease is first reported from South East Asia. Ann. Indian Acad Neurol 2019;22:225-27.  Back to cited text no. 6
    
7.
Katrak SM, Pauranik A, Desai SB, Mead S, Beck J, Brandner S, et al. Familial Creutzfeldt-Jakob Disease in an Indian Kindred. Ann Indian Acad Neurol 2019;22:458-61.  Back to cited text no. 7
  [Full text]  




 

Top
Print this article  Email this article

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (315 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed72    
    Printed1    
    Emailed0    
    PDF Downloaded20    
    Comments [Add]    

Recommend this journal